The Efficacy and Safety of Sofadil for Injection in the Treatment of Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.

Also called NCT04453800

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 236 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04453800
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04453800. Randomized; double masking; primary purpose treatment. Start 2016-10-01 (actual); primary completion 2018-01-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety of Sofadil for Injection in the Treatment of Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
sofadil【Neu2000KW】
Intervention (Drug)
Sofadil
Intervention (Drug)
Sofadil
Intervention (Other)
placebo
Lead sponsor
Peking University Third Hospital (class: other)

Record details

Record id
cardio:ct-nct04453800
Content hash
fa2f9edefc36ee77ab501ed68701e09411d1441f9f752cf6ed35772acb5784b7